FCPM III SERVICES B.V.
NAARDEN, P7 · CIK 2013410 · 13F filing filed 2025-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityFCPM III Services B.V. (NL)
- Kindventure
- Others nearbyBoston, MA, Almere Stad
- FamilyFCPM III SERVICES B.V. · 3 related pages
$369.2m
reported value
-10.8% vs Q1 2025
8positions
100.0%in top 10
1 new
1 added
1 reduced
0 sold out
vs Q1 2025
This report includes the holdings of 3 other managers that share the investment decisions:
- FORBION GROWTH II MANAGEMENT B.V. – reports through this filing
- Forbion Growth Management B.V. – reports through this filing
- Forbion IV Management B.V. – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| NEWAMSTERDAM PHARMA COMPANY NAMS | $192.5m52.16% | Reduced -303.2k |
| DYNE THERAPEUTICS INC DYN | $52.0m14.09% | Unchanged |
| REPLIMUNE GROUP INC REPL | $36.3m9.84% | Unchanged |
| ENGENE HOLDINGS INC COM | $35.1m9.50% | Unchanged |
| BICYCLE THERAPEUTICS PLC BCYC | $24.0m6.50% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $23.4m6.34% | Added +285.0k |
| RAPT THERAPEUTICS INC RAPT | $3.5m0.93% | New |
| ENGENE HOLDINGS INC *W EXP 10/31/202 | $2.4m0.64% | Unchanged |